1. Harris G (2014 Apr 14) Medicines made in India set off safety worries. New York Times. http://www.nytimes.com/2014/02/15/world/asia/medicines-made-in-india-set-off-safety-worries.html. Accessed 30 March 2015.
2. European Medicines Agency (2015 Jan 23) GVK Biosciences: European Medicines Agency recommends suspending medicines over flawed studies. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/01/news_detail_002256.jsp&mid=WC0b01ac058004d5c1. Accessed 30 March 2015.
3. Porecha M (2014 Apr 22) Vietnam shows the door to 45 Indian pharma companies. DNA (Diligent Media Corporation). http://www.dnaindia.com/mumbai/report-vietnam-shows-the-door-to-45-indian-pharma-companies-1980761. Accessed 30 March 2015.
4. Ministry of Health and Family Welfare (2003) Report of the expert committee on a comprehensive examination of drug regulatory issues, including the problem of spurious drugs. http://planningcommission.nic.in/reports/genrep/health/Final_Report_mashelkar.pdf. Accessed 30 March 2015.
5. Community Development Medicinal Unit, Health Action International Asia Pacific (2010 Dec 15) Report on research project: ‘fixed-dose combination in India, inception—marketing—a study’. http://www.cdmuindia.org/Pdf-files/Final-report-IFDCs.pdf. Accessed 30 March 2015.